Alison Karst is a Principal Scientist II in Oncology Research at Gilead Sciences, where they have progressed through various roles since 2018. Previously, Alison held positions as a Senior Scientist I at AbbVie, focusing on oncology drug discovery from 2014 to 2016, and as an Instructor in Medicine at Harvard Medical School, where they conducted ovarian cancer research from 2012 to 2014. Prior to these roles, Alison completed a postdoctoral fellowship at the Dana-Farber Cancer Institute, specializing in ovarian cancer research from 2008 to 2012. Alison earned a Ph.D. in Experimental Medicine from The University of British Columbia and a B.Sc. in Chemistry from Saint Mary's University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices